Adults Clinical Trial
— EATOfficial title:
Satiety Responses and Oral Processing Characteristics of Commonly Consumed Meals
NCT number | NCT05071170 |
Other study ID # | 2021-036 |
Secondary ID | |
Status | Completed |
Phase | |
First received | |
Last updated | |
Start date | May 5, 2021 |
Est. completion date | February 28, 2023 |
Verified date | August 2023 |
Source | Clinical Nutrition Research Centre, Singapore |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Observational |
Rationale: Oral processing behaviours (i.e. eating rate, bite size, chews per bite, oral exposure time etc.) play a major role in food ingestion and digestion, and potentially influence satiation and satiety responses . Experimental studies showed that a prolonged mastication or a slower eating rate is associated with decreased food intake , and increased satiety response per kcal consumed. Therefore, one possible approach to control the intake and appetite is to encourage eating behaviour that slow the rate of food intake and enhance the onset of satiety. Texture led changes to oral processing behaviours could offer an exciting opportunity to adapt an individual's response to structure properties of the food being consumed in a way that maintains the associated eating experience and satiety from food intake. However, no studies to date have investigated how differences in food processing influences food texture characteristics and oral processing behaviours, and subsequently impact on individuals' satiety responses and their subsequent food intake. The proposed study will examine the role of oral processing behaviours and/ or food processing (i.e. minimally processed, processed and ultra-processed) on satiety responses and the subsequent food intake Objectives: The objectives of the study are to characterise the differences in oral processing behaviours (i.e. eating rate, bite size, chew per bite, oral exposure time etc.) and satiety responses of meals that differ in their degree of processing, and to further investigate how texture-based differences in oral processing behaviours modified by degree of food processing influence the satiety responses (fullness over the time) and subsequent food intake. Study design: A total of 1 screening session (Session 1) and 4 test sessions (Sessions 2 to 5) and 2x2 randomised crossover design where participants receive 4 treatments (i.e. 4 test meals) over 4 test sessions Study population: Healthy males ( n=50), aged 21-50 years with BMI between 18-25 kg/m2 Intervention: Session 1 involves tasting of up to 16 food items and computer task to rate and evaluate their perception and health behaviour. Sessions 2 to 5 involve evaluation of sensory characteristics, video recording of participants eating, and wrist-worn accelerometer to track wrist movement while consuming the 4 test meals.
Status | Completed |
Enrollment | 48 |
Est. completion date | February 28, 2023 |
Est. primary completion date | February 28, 2023 |
Accepts healthy volunteers | |
Gender | Male |
Age group | 21 Years to 50 Years |
Eligibility | Inclusion Criteria: - Healthy male - Aged between 21 and 50-year-old - Are of normal weight (BMI 18-25kg/m2) - Stable weight for the previous 12 months (<5kg weight fluctuation in the previous year) - Healthy dentition and ability to bite, chew and swallow normally - No history of pain or discomfort in jaw movements or excessive teeth clenching or grinding - No caries or periodontal disease Exclusion Criteria: - Are a smoker - Have any dislikes, intolerances or allergies to foods or common food ingredients e.g. nuts, soya, wheat, gluten, cereal, fruits, biscuits, dairy products, rice, vegetable, meat, seafood, sugar and sweetener, gelatin, natural food colourings or flavourings (e.g. MSG), etc. - Have any specific dietary requirements and/ or restrictions (e.g. Vegan/ vegetarian, religious beliefs, lactose intolerance, calorie restricted diet etc.) - Have sinus problems that affect your taste and smell - Have known glucose-6-phosphate dehydrogenase (G6PD) deficiency - Are taking insulin or medication known to affect your appetite or metabolism - Have major chronic diseases such as heart disease, cancer or diabetes mellitus - Have active Tuberculosis (TB) or currently receiving treatment for TB - Have any known Chronic Infection or known to suffer from or have previously suffered from or is a carrier of Hepatitis B Virus (HBV), Hepatitis C Virus (HCV), Human Immunodeficiency Virus (HIV) - Are a member of the research team or their immediate family members. Immediate family member is defined as a spouse, parent, child, or sibling, whether biological or legally adopted - Are enrolled in a concurrent research study judged not to be scientifically or medically compatible with the study of the CNRC |
Country | Name | City | State |
---|---|---|---|
Singapore | Singapore Institute of Food and Biotechnology Innovation (SIFBI)/Clinical Nutrition Research Centre | Singapore |
Lead Sponsor | Collaborator |
---|---|
Clinical Nutrition Research Centre, Singapore |
Singapore,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Oral processing behaviour | Participants will be video-recorded during the lunch sessions to measure oral processing behaviour (e.g., derived from number of bites, chews, swallows and eating duration) of the test fixed portion test meals using an annotation software. | During test session 2, Up to 20 minutes | |
Primary | Oral processing behaviour | Participants will be video-recorded during the lunch sessions to measure oral processing behaviour (e.g., derived from number of bites, chews, swallows and eating duration) of the test fixed portion test meals using an annotation software. | During test session 3, Up to 20 minutes | |
Primary | Oral processing behaviour | Participants will be video-recorded during the lunch sessions to measure oral processing behaviour (e.g., derived from number of bites, chews, swallows and eating duration) of the test fixed portion test meals using an annotation software. | During test session 4, Up to 20 minutes | |
Primary | Oral processing behaviour | Participants will be video-recorded during the lunch sessions to measure oral processing behaviour (e.g., derived from number of bites, chews, swallows and eating duration) of the test fixed portion test meals using an annotation software. | During test session 5, Up to 20 minutes | |
Primary | Change in Post breakfast satiety responses | Participants will be asked rate their appetite sensations using a visual analogue scale (VAS) pre- and post meals. VAS is anchored at 'Not at all' (0) to 'Extremely' (100), where a higher score will indicate greater intensity. | During test session 2, at 15 or 30 minutes' intervals, up to 4 hours each | |
Primary | Change in Post breakfast satiety responses | Participants will be asked rate their appetite sensations using a visual analogue scale (VAS) pre- and post meals. VAS is anchored at 'Not at all' (0) to 'Extremely' (100), where a higher score will indicate greater intensity. | During test session 3, at 15 or 30 minutes' intervals, up to 4 hours each | |
Primary | Change in Post breakfast satiety responses | Participants will be asked rate their appetite sensations using a visual analogue scale (VAS) pre- and post meals. VAS is anchored at 'Not at all' (0) to 'Extremely' (100), where a higher score will indicate greater intensity. | During test session 4, at 15 or 30 minutes' intervals, up to 4 hours each | |
Primary | Change in Post breakfast satiety responses | Participants will be asked rate their appetite sensations using a visual analogue scale (VAS) pre- and post meals. VAS is anchored at 'Not at all' (0) to 'Extremely' (100), where a higher score will indicate greater intensity. | During test session 5, at 15 or 30 minutes' intervals, up to 4 hours each | |
Primary | Change in Post lunch satiety responses | Participants will be asked rate their appetite sensations using a visual analogue scale (VAS) pre- and post meals. VAS is anchored at 'Not at all' (0) to 'Extremely' (100), where a higher score will indicate greater intensity. | During test session 2, 15 or 30 minutes' intervals, up to 2 hours each | |
Primary | Change in Post lunch satiety responses | Participants will be asked rate their appetite sensations using a visual analogue scale (VAS) pre- and post meals. VAS is anchored at 'Not at all' (0) to 'Extremely' (100), where a higher score will indicate greater intensity. | During test session 3, 15 or 30 minutes' intervals, up to 2 hours each | |
Primary | Change in Post lunch satiety responses | Participants will be asked rate their appetite sensations using a visual analogue scale (VAS) pre- and post meals. VAS is anchored at 'Not at all' (0) to 'Extremely' (100), where a higher score will indicate greater intensity. | During test session 4, 15 or 30 minutes' intervals, up to 2 hours each | |
Primary | Change in Post lunch satiety responses Session 5 | Participants will be asked rate their appetite sensations using a visual analogue scale (VAS) pre- and post meals. VAS is anchored at 'Not at all' (0) to 'Extremely' (100), where a higher score will indicate greater intensity. | During test session 5, 15 or 30 minutes' intervals, up to 2 hours each | |
Primary | Subsequent food intake post test meal | Participants will be asked to bring a food dairy home to record their food and beverage intake for the rest of the test day. This is to assess participants' calorie intake for the remaining day on the test session. | During test session 2, up to 0000hrs | |
Primary | Subsequent food intake post test meal | Participants will be asked to bring a food dairy home to record their food and beverage intake for the rest of the test day. This is to assess participants' calorie intake for the remaining day on the test session. | During test session 3, up to 0000hrs | |
Primary | Subsequent food intake post test meal | Participants will be asked to bring a food dairy home to record their food and beverage intake for the rest of the test day. This is to assess participants' calorie intake for the remaining day on the test session. | During test session 4, up to 0000hrs | |
Primary | Subsequent food intake post test meal | Participants will be asked to bring a food dairy home to record their food and beverage intake for the rest of the test day. This is to assess participants' calorie intake for the remaining day on the test session. | During test session 5, up to 0000hrs |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT04704726 -
Examining Essentialistic Beliefs About Food
|
||
Active, not recruiting |
NCT06042218 -
Xiaxi Program for Back Health
|
N/A | |
Not yet recruiting |
NCT06054542 -
Turkish Version of Digital Eye Strain Questionnaire (DESQ)
|
||
Completed |
NCT03582943 -
Effects of RLIC on Motor Learning in Middle-aged and Older Adults
|
Phase 1 | |
Recruiting |
NCT06086145 -
Biomarker-estimated Flavanol Intake in Davis (FID)
|
||
Completed |
NCT04589221 -
Sensory and Oral Processing Characteristics of Commonly Consumed Foods
|
||
Completed |
NCT01995838 -
A Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel-group, Bayesian Adaptive Randomization Design, Dose Response Study of the Efficacy of E2006 in Adults and Elderly Subjects With Chronic Insomnia
|
Phase 2 | |
Completed |
NCT03962517 -
Effect of GEMS-H on Locomotor Function in Adults
|
N/A | |
Completed |
NCT04683432 -
The Texture, Eating Rate and Glycaemic Index (TERAGI) Study
|
||
Completed |
NCT04860349 -
Is High Intensity Interval Training Effective to Reduce the Waist Circumference and Fat Percentage at Trunk Region
|
N/A | |
Recruiting |
NCT04422782 -
New Tools for Predicting Capillary Leak Shock During Dengue Fever
|
N/A | |
Recruiting |
NCT04881292 -
RF Based QIMT & QAS Study on Chinese Adults
|
||
Not yet recruiting |
NCT04837170 -
Safety and Efficacy Evaluation of S (+) - Ketamine in Adults
|
Phase 4 | |
Completed |
NCT04058769 -
Software-guided Guideline Implementation in Premedication
|
N/A | |
Completed |
NCT05741047 -
Comparative Effects of a2 Skim Milk on Mild Cognitive Impairment in Older Adults
|
N/A | |
Active, not recruiting |
NCT02398825 -
Activity and Risk Profile of Ponatinib in Chronic Phase Patients With Chronic Myeloid Leukemia Resistant to Imatinib
|
Phase 2 | |
Completed |
NCT05460585 -
Cerebral Oxygenation Values in Healthy Adults Volunteers Measured With RheoPatch and NIRO-200NX
|
||
Completed |
NCT04843202 -
Clinical Guidelines in Premedication Visit
|
||
Completed |
NCT04522063 -
Variation in Food Intakes, Physical Activity, and Psychological Stress on Fluctuations in 24-hr Plasma Glucose Levels
|
||
Recruiting |
NCT04693949 -
Effect of Nano-structured Alumina Coating on the Bond Strength of Zirconia Resin-bonded Fixed Dental Prostheses
|
N/A |